Álvaro Morales-Molina
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 06, 2023
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing.Alvaro Morales-Molina, Miguel Ángel Rodriguez-Milla, Stefano Gambera
|Mar 19, 2021
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.Alvaro Morales-Molina, Stefano Gambera, Angela Leo
|Jul 26, 2020
Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1+ Subsets in Mouse Immunocompetent Models.Alvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Alicia Gimenez-Sanchez
|May 28, 2020
AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses.Miguel Ángel Rodríguez-Milla, Alvaro Morales-Molina, Ana Judith Perisé-Barrios
|Oct 17, 2018
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells.Rafael Moreno, Carlos Alberto Fajardo, Marti Farrera-Sal
|Aug 02, 2018
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.Álvaro Morales-Molina, Stefano Gambera, Teresa Cejalvo
Pageof 1
Frequent Collaborators
6 joint publications
Javier García-Castro
4 joint publications
Ana Judith Perisé-Barrios
2 joint publications
Stefano Gambera
2 joint publications
Teresa Cejalvo
2 joint publications
Miguel Ángel Rodríguez-Milla
1 joint publications
Rafael Moreno
1 joint publications
Marti Farrera-Sal
1 joint publications
Ahmed Abdullah Al-Zaher
1 joint publications
Belén de Andrés
1 joint publications
María-Luisa Gaspar
